Pubblicazioni scientifiche

Rizzo A.; Ricci A.D.; Gadaleta-Caldarola G.; Brandi G., Toward personalized therapy for cholangiocarcinoma: new insights and challenges, «EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY», 2021, 15, pp. 1241 - 1243 [Articolo in rivista]

Rizzo A.; Ricci A.D.; Brandi G., Pemigatinib: Hot topics behind the first approval of a targeted therapy in cholangiocarcinoma, «CANCER TREATMENT AND RESEARCH COMMUNICATIONS», 2021, 27, pp. 1 - 6 [Articolo in rivista] Open Access

Rizzo A.; Ricci A.D.; Brandi G., Futibatinib, an investigational agent for the treatment of intrahepatic cholangiocarcinoma: evidence to date and future perspectives, «EXPERT OPINION ON INVESTIGATIONAL DRUGS», 2021, 30, pp. 317 - 324 [Articolo in rivista]

Rizzo A.; Ricci A.D.; Brandi G., Immune-based combinations for advanced hepatocellular carcinoma: Shaping the direction of first-line therapy, «FUTURE ONCOLOGY», 2021, 17, pp. 755 - 757 [Articolo in rivista]

Rizzo A.; Brandi G., Pitfalls, challenges, and updates in adjuvant systemic treatment for resected biliary tract cancer, «EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY», 2021, 15, pp. 547 - 554 [Articolo in rivista]

Di Federico A.; Tateo V.; Parisi C.; Formica F.; Carloni R.; Frega G.; Rizzo A.; Ricci D.; Di Marco M.; Palloni A.; Brandi G., Hacking pancreatic cancer: Present and future of personalized medicine, «PHARMACEUTICALS», 2021, 14, pp. 1 - 19 [Articolo in rivista] Open Access

Rizzo A.; Ricci A.D.; Brandi G., Pd‐l1, tmb, msi, and other predictors of response to immune checkpoint inhibitors in biliary tract cancer, «CANCERS», 2021, 13, pp. 1 - 11 [Articolo in rivista] Open Access

Zhu, A. X.; Finn, R. S.; Kang, Y. -K.; Yen, C. -J.; Galle, P. R.; Llovet, J. M.; Assenat, E.; Brandi, G.; Motomura, K.; Ohno, I.; Daniele, B.; Vogel, A.; Yamashita, T.; Hsu, C. -H.; Gerken, G.; Bilbruck, J.; Hsu, Y.; Liang, K.; Widau, R. C.; Wang, C.; Abada, P.; Kudo, M., Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab, «BRITISH JOURNAL OF CANCER», 2021, 124, pp. 1388 - 1397 [Articolo in rivista] Open Access

Rovesti G.; Leone F.; Brandi G.; Cesario S.; Scartozzi M.; Niger M.; Yoo C.; Filippi R.; Casagrande M.; Silvestris N.; Santini D.; Faloppi L.; Palloni A.; Aglietta M.; Bernardini L.; Cho H.; Lai E.; Fenocchio E.; Pircher C.; Iacono D.; De Lorenzo S.; Sperti E.; Massa V.; De Braud F.; Jeong J.H.; Aprile G.; Burgio V.; Cascinu S.; Casadei-Gardini A., A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index, «JOURNAL OF GASTROINTESTINAL CANCER», 2021, 1, pp. 1 - 9 [Articolo in rivista]

Rovesti G.; Leone F.; Brandi G.; Fornaro L.; Scartozzi M.; Niger M.; Yoo C.; Caputo F.; Filippi R.; Casagrande M.; Silvestris N.; Santini D.; Faloppi L.; Palloni A.; Aglietta M.; Vivaldi C.; Cho H.; Lai E.; Fenocchio E.; Nichetti F.; Pella N.; De Lorenzo S.; Di Maio M.; Vasile E.; de Braud F.; Jeong J.H.; Aprile G.; Orsi G.; Cascinu S.; Casadei-Gardini A., Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index, «JOURNAL OF GASTROINTESTINAL CANCER», 2021, 1, pp. 1 - 10 [Articolo in rivista]

Ricci A.D.; Rizzo A.; Brandi G., DNA damage response alterations in gastric cancer: Knocking down a new wall, «FUTURE ONCOLOGY», 2021, 17, pp. 865 - 868 [Articolo in rivista]

Filippi R.; Leone F.; Fornaro L.; Aprile G.; Casadei-Gardini A.; Silvestris N.; Palloni A.; Satolli M.A.; Scartozzi M.; Russano M.; Lutrino S.E.; Lombardi P.; Frega G.; Garattini S.K.; Vivaldi C.; Spadi R.; Giulia O.; Fenocchio E.; Brunetti O.; Aglietta M.; Brandi G., Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis, «JOURNAL OF CHEMOTHERAPY», 2021, 1, pp. 1 - 10 [Articolo in rivista]

Rizzo A.; Santoni M.; Mollica V.; Fiorentino M.; Brandi G.; Massari F., Microbiota and prostate cancer, «SEMINARS IN CANCER BIOLOGY», 2021, 1044, pp. 1 - 8 [Articolo in rivista]

Rizzo A.; Ricci A.D.; Brandi G., IDH inhibitors in advanced cholangiocarcinoma: Another arrow in the quiver?, «CANCER TREATMENT AND RESEARCH COMMUNICATIONS», 2021, 27, pp. 1 - 6 [Articolo in rivista] Open Access

Filippi R.; Montagnani F.; Lombardi P.; Fornaro L.; Aprile G.; Casadei-Gardini A.; Faloppi L.; Palloni A.; Satolli M.A.; Scartozzi M.; Citarella F.; Lutrino S.E.; Vivaldi C.; Silvestris N.; Rovesti G.; Rimini M.; Aglietta M.; Brandi G.; Leone F., A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy, «ACTA ONCOLOGICA», 2021, 60, pp. 1317 - 1324 [Articolo in rivista]

Massari F.; Di Nunno V.; Guida A.; Costa Silva C.A.; Derosa L.; Mollica V.; Colomba E.; Brandi G.; Albiges L., Addition of Primary Metastatic Site on Bone, Brain, and Liver to IMDC Criteria in Patients With Metastatic Renal Cell Carcinoma: A Validation Study, «CLINICAL GENITOURINARY CANCER», 2021, 19, pp. 32 - 40 [Articolo in rivista]

Rizzo A.; Ricci A.D.; Brandi G., Recent advances of immunotherapy for biliary tract cancer, «EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY», 2021, 15, pp. 527 - 536 [Articolo in rivista]

Filippini D.M.; Di Federico A.; Lenzi B.; Nobili E.; Brocchi S.; Malvi D.; Brandi G., Critical diagnostic delay associated with unusual presentation of hepatocellular carcinoma (Hcc) with orbital metastases: A case report, «ANNALS OF PALLIATIVE MEDICINE», 2021, 10, pp. 8474 - 8478 [Articolo in rivista] Open Access

Rizzo A.; Brandi G., Adjuvant systemic treatment in resected biliary tract cancer: State of the art, controversies, and future directions, «CANCER TREATMENT AND RESEARCH COMMUNICATIONS», 2021, 27, pp. 1 - 7 [Articolo in rivista] Open Access

Rizzo A.; Brandi G., Novel targeted therapies for advanced cholangiocarcinoma, «MEDICINA», 2021, 57, pp. 1 - 3 [Articolo in rivista] Open Access